Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06615817 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intermittent Fasting, Mediterranean Diet and NAFLD

Study acronym: RC2024-21
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 26, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
This study aims to evaluate the effects of Intermittent Fasting (IF) 14/10 compared with the Low Glycemic Index Mediterranean Diet on NAFLD.
Trial Details
NCT Number NCT06615817
Lead Sponsor Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Conditions
(from sponsor)		 NAFLD, Obesity, Intermittent Fasting, Mediterranean Diet
Related terms Intermittent Fasting, Liver Diseases, Non-alcoholic Fatty Liver Disease, Obesity
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov